Mannheim, Germany

Alexander Licht

This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignee: Roche Diabetes Care, Inc.. Active years: 2022-2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Alexander Licht: Innovator in Medical Device Technology

Introduction: Alexander Licht is an inventor based in Weinheim, Germany. He has made significant contributions to the field of medical devices, particularly in the area of therapeutic implantation and efficiency detection systems. Although he currently holds no granted patents, his innovative ideas are reflected in his latest patent applications.

Latest Patent Applications: Alexander Licht's recent patent applications include "Means and Methods for Implanting Cells Secreting a Therapeutic Compound." This application describes a device for implantation into a mammalian host, featuring a dialysis tube with a specific outer diameter and a dialysis membrane with a defined molecular weight cutoff. The device is designed to contain a therapeutic composition with cells that secrete a therapeutic compound, embedded in a matrix material. Another notable application is "Non-Invasive Medical Device Efficiency and Fault Detection Systems and Methods of Use." This application outlines methods and systems for detecting the efficiency of medical devices using a photoplethysmography (PPG) sensor device, which alerts users in case of insufficient therapy treatment delivery.

Conclusion: Alexander Licht is an innovative inventor whose work in medical device technology showcases his commitment to improving therapeutic methods. His latest patent applications reflect his dedication to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…